ADC Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADCT and other ETFs, options, and stocks.About ADCT
ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602.
CEOAmeet Mallik
CEOAmeet Mallik
Employees265
Employees265
HeadquartersEpalinges, Vaud
HeadquartersEpalinges, Vaud
Founded2011
Founded2011
Employees265
Employees265
ADCT Key Statistics
Market cap451.53M
Market cap451.53M
Price-Earnings ratio-2.44
Price-Earnings ratio-2.44
Dividend yield—
Dividend yield—
Average volume722.74K
Average volume722.74K
High today$3.67
High today$3.67
Low today$3.50
Low today$3.50
Open price$3.58
Open price$3.58
Volume176.17K
Volume176.17K
52 Week high$4.80
52 Week high$4.80
52 Week low$1.05
52 Week low$1.05
Stock Snapshot
ADC Therapeutics(ADCT) stock is priced at $3.65, giving the company a market capitalization of 451.53M. It carries a P/E multiple of -2.44.
On 2026-01-07, ADC Therapeutics(ADCT) stock moved within a range of $3.50 to $3.67. With shares now at $3.65, the stock is trading +4.1% above its intraday low and -0.7% below the session's peak.
Trading volume for ADC Therapeutics(ADCT) stock has reached 176.17K, versus its average volume of 722.74K.
Over the past 52 weeks, ADC Therapeutics(ADCT) stock has traded between a high of $4.80 and a low of $1.05.
Over the past 52 weeks, ADC Therapeutics(ADCT) stock has traded between a high of $4.80 and a low of $1.05.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ADCT. This list is generated using Robinhood data, and it’s not a recommendation.